Anti-Argonaute antibodies as a potential biomarker in NMOSD.

Sara Carta Le Duy DoVeronique RogemondNathalie DeracheHugo ChaumontAgnès FromontSebastien CabassonMarine Boudot de la MotteJerome HonnoratRomain Marignier

Published in: Journal of neurology, neurosurgery, and psychiatry (2023)

Ago-Abs are present in a subset of patients with NMOSD and, in some cases, represent the only biomarker of an autoimmune process. Their presence is associated with a myelitis phenotype and a severe disease course.

Keyphrases

drug induced
multiple sclerosis
early onset